Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Jiangsu Cancer Institute & Hospital

2 clinical trials · 2 recruiting · OTHER

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by Jiangsu Cancer Institute & Hospital

RECRUITINGNCT06198868

MRD-guided Prognosis Prediction and Adjuvant Treatment Based on CTC and ctDNA in NSCLC

This is a prospective cohort study, which aims to evaluate the effectiveness and superiority of a novel minimal residual disease-guided prognosis monitoring and adjuvant treatment...

Sponsor: Jiangsu Cancer Institute & HospitalEnrolling: 601 location
Non-small Cell Lung Cancer
RECRUITINGPhase 2NCT07311577

Disitamab Vedotin Combined With Platinum and Bevacizumab as First-Line and Maintenance Therapy for HER2-Expressing,...

This is a prospective, multicenter, phase II study designed to evaluate the efficacy and safety of disitamab vedotin combined with platinum plus bevacizumab as first-line therapy...

Sponsor: Jiangsu Cancer Institute & HospitalEnrolling: 432 locations
Ovarian Cancer MetastaticOvarian Cancer Metastatic Recurrent